Home » Topics » Science » New compound

New compound
RSS

AUR-103 in combination with azacytidine and bortezomib for myeloma and leukemia treatment

April 20, 2022

Plexium compound shows the promise of BRD4 degradation for prostate cancer

April 20, 2022

TLR2/6 agonist AXA-042 shows antitumor activity and tolerability in vivo

April 20, 2022

IKZF2 degrader PLX-4107 shows promise as cancer immunotherapeutic

April 19, 2022

FGFR2-selective inhibitor CGT-0292 shows promise for treating hyperphosphatemia

April 13, 2022

Peptidomimetic TMPRSS2 inhibitor shows prophylactic and therapeutic activity against SARS-CoV-2 VOCs

April 7, 2022

Researchers present [11C]JMJ-81 as a new PET tracer for brain PDE4D quantification

April 4, 2022

AZD-9574: a selective PARP1 inhibitor suitable for cancer treatment

April 4, 2022

AC-0027136 improves memory impairment and mitochondrial function

March 31, 2022

Sosei Heptares' GLP-1/2 agonist HTL-0030023 shows promising results for treating NAFLD and NASH

March 28, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...